Home World News EMA Adopts a Positive Opinion for a New Route of Administration Together... World News EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab By Ogkologos - May 8, 2026 205 0 Facebook Twitter Google+ Pinterest WhatsApp It is a cancer medicine used to treat adult patients with multiple myeloma Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Hypogammaglobulinemia and Sars-CoV-2 Viraemia Determine COVID-19 Severity in Patients with Haematological... July 16, 2021 EMA Recommends Extension of Therapeutic Indications for Axicabtagene Ciloleucel May 27, 2022 Expectant Mom with “Blocked Milk Duct” Discovers She Has Cancer at... April 27, 2021 Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities October 22, 2021 Load more HOT NEWS Pirtobrutinib Shows Efficacy in Patients with Heavily Pretreated CLL or SLL... Doctors Think Woman Has A Brain Tumor, But Then They Open... Two Drugs Work Together to Block ‘Master Regulator’ of Breast, Other... Long-Term Clinical Benefit with Nivolumab Plus Ipilimumab Extends Beyond Treatment Discontinuation...
